Headlines

Israel: Covid drug saves 47 of 50 severe patients in trial

Byadmin

Dec 18, 2021 , , , , ,

Bonus BioGroup says its MesenCure experimental treatment resulted in 94% survival rate of trial subjects and cut hospitalization time in half.  Read print story.

By Abigail Klein Leichman | posted 11/25/2021 

By admin

Related Post

Headlines

Germany: Authorities foil ISIS supporter’s plot to attack Israeli embassy

Nov 22, 2024 admin
Headlines

USA: NFL wife shares video of husband reading Proverbs 31 over her, newborn

Nov 21, 2024 admin
Headlines

Netherlands: Most disturbing anti-Semitism spike since WWII as 2,000  airlifted out

Nov 20, 2024 admin